138 related articles for article (PubMed ID: 27311131)
1. Sensitizing nanoparticle based platinum(IV) drugs by curcumin for better chemotherapy.
Kang X; Zhao C; Yan L; Qi R; Jing X; Wang Z
Colloids Surf B Biointerfaces; 2016 Sep; 145():812-819. PubMed ID: 27311131
[TBL] [Abstract][Full Text] [Related]
2. Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer.
Scarano W; de Souza P; Stenzel MH
Biomater Sci; 2015 Jan; 3(1):163-74. PubMed ID: 26214199
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-mediated delivery of multinuclear platinum(IV) prodrugs with enhanced drug uptake and the activity of overcoming drug resistance.
Gao Y; Jiang M; Ma Y; Wu S; Li W; Yang X; Li Y; Jing X; Jiang H
Anticancer Drugs; 2016 Feb; 27(2):77-83. PubMed ID: 26473527
[TBL] [Abstract][Full Text] [Related]
4. Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo.
Yu C; Ding B; Zhang X; Deng X; Deng K; Cheng Z; Xing B; Jin D; Ma P; Lin J
Biomaterials; 2018 Feb; 155():112-123. PubMed ID: 29175080
[TBL] [Abstract][Full Text] [Related]
5. Platin-
Banik B; Ashokan A; Choi JH; Surnar B; Dhar S
Dalton Trans; 2023 Mar; 52(12):3575-3585. PubMed ID: 36723189
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models.
Arzuman L; Beale P; Yu JQ; Proschogo N; Huq F
Anticancer Res; 2014 Dec; 34(12):7077-90. PubMed ID: 25503135
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable polymer - cisplatin(IV) conjugate as a pro-drug of cisplatin(II).
Xiao H; Qi R; Liu S; Hu X; Duan T; Zheng Y; Huang Y; Jing X
Biomaterials; 2011 Oct; 32(30):7732-9. PubMed ID: 21783244
[TBL] [Abstract][Full Text] [Related]
8. Turning Ineffective Transplatin into a Highly Potent Anticancer Drug via a Prodrug Strategy for Drug Delivery and Inhibiting Cisplatin Drug Resistance.
Li W; Jiang M; Cao Y; Yan L; Qi R; Li Y; Jing X
Bioconjug Chem; 2016 Aug; 27(8):1802-6. PubMed ID: 27380489
[TBL] [Abstract][Full Text] [Related]
9. Imidazole modified Pt(iv) prodrug-loaded multi-stage pH responsive nanoparticles to overcome cisplatin resistance.
Kang X; Wang Y; Chen Z; Wu Y; Chen H; Yang X; Yu C
Chem Commun (Camb); 2020 Sep; 56(76):11271-11274. PubMed ID: 32830841
[TBL] [Abstract][Full Text] [Related]
10. Thermogelling polymer-platinum(IV) conjugates for long-term delivery of cisplatin.
Shen W; Luan J; Cao L; Sun J; Yu L; Ding J
Biomacromolecules; 2015 Jan; 16(1):105-15. PubMed ID: 25435165
[TBL] [Abstract][Full Text] [Related]
11. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
12. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G
Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044
[TBL] [Abstract][Full Text] [Related]
13. A hybrid platinum drug dichloroacetate-platinum(II) overcomes cisplatin drug resistance through dual organelle targeting.
Zhang Y; Guo G; Ma B; Du R; Xiao H; Yang X; Li W; Gao Y; Li Y; Jing X
Anticancer Drugs; 2015 Aug; 26(7):698-705. PubMed ID: 25811961
[TBL] [Abstract][Full Text] [Related]
14. Multipronged Design of Light-Triggered Nanoparticles To Overcome Cisplatin Resistance for Efficient Ablation of Resistant Tumor.
Li Y; Deng Y; Tian X; Ke H; Guo M; Zhu A; Yang T; Guo Z; Ge Z; Yang X; Chen H
ACS Nano; 2015 Oct; 9(10):9626-37. PubMed ID: 26365698
[TBL] [Abstract][Full Text] [Related]
15. Polymer nanoparticle delivery of dichloroacetate and DACH-Pt to enhance antitumor efficacy and lower systemic toxicity.
Yang Q; Cai J; Sun S; Kang X; Guo J; Zhu Y; Yan L; Jing X; Wang Z
Biomater Sci; 2016 Apr; 4(4):661-9. PubMed ID: 26810463
[TBL] [Abstract][Full Text] [Related]
16. Monofunctional Platinum-containing Pyridine-based Ligand Acts Synergistically in Combination with the Phytochemicals Curcumin and Quercetin in Human Ovarian Tumour Models.
Arzuman L; Beale P; Yu JQ; Huq F
Anticancer Res; 2015 May; 35(5):2783-94. PubMed ID: 25964558
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle delivery of photosensitive Pt(IV) drugs for circumventing cisplatin cellular pathway and on-demand drug release.
Du R; Xiao H; Guo G; Jiang B; Yan X; Li W; Yang X; Zhang Y; Li Y; Jing X
Colloids Surf B Biointerfaces; 2014 Nov; 123():734-41. PubMed ID: 25454669
[TBL] [Abstract][Full Text] [Related]
18. Delivery of platinum (II) drugs with bulky ligands in trans-geometry for overcoming cisplatin drug resistance.
Yang X; Yu Y; Huang X; Chen Q; Wu H; Wang R; Qi R; Miao Y; Qiu Y
Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():96-104. PubMed ID: 30606608
[TBL] [Abstract][Full Text] [Related]
19. Synergism from combinations of tris(benzimidazole) monochloroplatinum(II) chloride with capsaicin, quercetin, curcumin and cisplatin in human ovarian cancer cell lines.
Arzuman L; Beale P; Chan C; Yu JQ; Huq F
Anticancer Res; 2014 Oct; 34(10):5453-64. PubMed ID: 25275041
[TBL] [Abstract][Full Text] [Related]
20. Studies on combination of platinum drugs cisplatin and oxaliplatin with phytochemicals anethole and curcumin in ovarian tumour models.
Nessa MU; Beale P; Chan C; Yu JQ; Huq F
Anticancer Res; 2012 Nov; 32(11):4843-50. PubMed ID: 23155250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]